Drug Trial Radar · NCT01727726
A Study of Flexible-dose Brexpiprazole as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder, the Delphinus Trial
Last checked: Nov 20, 2026Latest source record: Jun 8, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
2,182
Actual
Start
Dec 2012
Primary completion
Oct 17, 2016
Study completion Nov 10, 2016
Sponsor
- Lead sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.Otsuka
- Sponsor type
- Industry
- First posted
- Nov 16, 2012
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To compare the efficacy of brexpiprazole (flexible dose) with placebo as adjunctive therapy to an assigned open label antidepressant therapy (ADT) in the proposed subject population with MDD.
Conditions
- Depressive Disorder
- Depression
- Depressive Disorder, Major
- Mood Disorders
- Mental Disorders
Interventions
BrexpiprazoleDrug
tablet/capsule
Seroquel XRDrug
tablet/capsule
PlaceboDrug
tablet/capsule
Primary outcomes
What the sponsor says the trial is designed to measure.
- Montgomery Asberg Depression Rating Scale (MADRS)Time frame: Randomization Visit (week 8 or week 10) to End of Double-Blind Treatment (week 14 or week 16).
Locations
76 sites in 7 countries. Site status is shown where the registry gives one.
Site not named
Birmingham, Alabama
Site not named
Phoenix, Arizona
Site not named
Little Rock, Arkansas
Site not named
Bellflower, California
Site not named
Beverly Hills, California
Site not named
Costa Mesa, California
Site not named
Glendale, California
Site not named
Irvine, California
Site not named
Redlands, California
Site not named
San Diego, California
Site not named
Upland, California
Site not named
Gainesville, Florida
Site not named
Jacksonville, Florida
Site not named
Jacksonville Beach, Florida
Site not named
Leesburg, Florida
Site not named
Melbourne, Florida
Site not named
Miami, Florida
Site not named
Miami, Florida
Site not named
Oakland Park, Florida
Site not named
Orange City, Florida
Site not named
Orlando, Florida
Site not named
Decatur, Georgia
Site not named
Lake Charles, Louisiana
Site not named
Baltimore, Maryland
Site not named
Belmont, Massachusetts
Site not named
Roslindale, Massachusetts
Site not named
Watertown, Massachusetts
Site not named
Creve Coeur, Missouri
Site not named
Lebanon, New Hampshire
Site not named
New York, New York
Site not named
New York, New York
Site not named
Columbus, Ohio
Site not named
Dayton, Ohio
Site not named
Edmond, Oklahoma
Site not named
Portland, Oregon
Site not named
Salem, Oregon
Site not named
Dallas, Texas
Site not named
Murray, Utah
Site not named
Herndon, Virginia
Site not named
Richmond, Virginia
Showing 40 of 76 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.